Ritchie Lab - LPA variants are associated with residual cardiovascular risk in patients receiving statins.

Wei, W.-Q., Li, X., Feng, Q., Kubo, M., Kullo, I. J., Peissig, P. L., … Denny, J. C. (2018). LPA variants are associated with residual cardiovascular risk in patients receiving statins. Circulation, 138(17), 1839–1849. doi:10.1161/circulationaha.117.031356